Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares 1 3 Year Treasury Bond ETF (SHY) vs BIO-TECHNE Corp (TECH) Price & Performance

iShares 1 3 Year Treasury Bond ETFTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

iShares 1 3 Year Treasury Bond ETF vs BIO-TECHNE Corp — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.89, while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp pays a 0.45% dividend while iShares 1 3 Year Treasury Bond ETF pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

SHYTECH
Sector
Fixed IncomeHealth
52-Week High
$83.18$72.12
52-Week Low
$81.79$43.31
Market Cap
$11.16B
Enterprise Value
$11.24B
Dividend Yield
0.45%

Returns comparison

Trailing returns across standard periods

About iShares 1 3 Year Treasury Bond ETF

SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.

Read more on SHY

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH